Crossject S.A.

Crossject S.A.verified

ALCJ.PA

Price:

$2.175

Market Cap:

$112.71M

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.

Industry

Medical - Instruments & Supplies

IPO Date

2014-02-20

Stock Exchange

PAR

Ticker

ALCJ.PA

The Enterprise Value as of December 2025 (TTM) for Crossject S.A. (ALCJ.PA) is 124.04M

According to Crossject S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 124.04M. This represents a change of 0.78% compared to the average of 123.08M of the last 4 quarters.

Crossject S.A. (ALCJ.PA) Historical Enterprise Value (quarterly & annually)

How has ALCJ.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of Crossject S.A. over the last ten years is 80.86M. The current 124.04M Enterprise Value has changed 15.24% with respect to the historical average. Over the past ten years (40 quarters), ALCJ.PA's Enterprise Value was at its highest in in the December 2023 quarter at 196.30M. The Enterprise Value was at its lowest in in the January 2010 quarter at 0.

Quarterly (TTM)
Annual

Average

80.86M

Median

74.82M

Minimum

17.91M

Maximum

199.54M

Crossject S.A. (ALCJ.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Crossject S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 170.19%

Maximum Annual Enterprise Value = 199.54M

Minimum Annual Increase = -54.10%

Minimum Annual Enterprise Value = 17.91M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024111.76M-43.99%
2023199.54M59.31%
2022125.25M44.67%
202186.58M1.16%
202085.58M76.86%
201948.39M170.19%
201817.91M-54.10%
201739.02M27.78%
201630.54M-52.33%
201564.07M45.04%

Crossject S.A. (ALCJ.PA) Average Enterprise Value

How has ALCJ.PA Enterprise Value performed in the past?

The current Enterprise Value of Crossject S.A. (ALCJ.PA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

145.52M

5-year avg

121.74M

10-year avg

80.86M

Crossject S.A. (ALCJ.PA) Enterprise Value vs. Peers

How is ALCJ.PA’s Enterprise Value compared to its peers?

Crossject S.A.’s Enterprise Value is less than Median Technologies S.A. (134.58M), greater than Sensorion S.A. (46.54M), less than OSE Immunotherapeutics S.A. (142.05M), greater than AB Science S.A. (90.97M), greater than Klea Holding (79.19M), less than ABIONYX Pharma S.A. (135.78M), less than Innate Pharma S.A. (127.45M), less than Adocia S.A. (142.26M), greater than Eurofins-Cerep S.A. (76.70M), greater than Affluent Medical S.A. (74.24M),

Build a custom stock screener for Crossject S.A. (ALCJ.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crossject S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crossject S.A. (ALCJ.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crossject S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Crossject S.A.'s Enterprise Value?

What is the highest Enterprise Value for Crossject S.A. (ALCJ.PA)?

What is the 3-year average Enterprise Value for Crossject S.A. (ALCJ.PA)?

What is the 5-year average Enterprise Value for Crossject S.A. (ALCJ.PA)?

How does the current Enterprise Value for Crossject S.A. (ALCJ.PA) compare to its historical average?